Byron Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Agra, Uttar Pradesh, India, established in 2007.
2007 Agra, Uttar Pradesh, India Struck Off
Last Updated:
Access Report
About Byron Pharma Private Limited

Byron Pharma Private Limited, a struck off private limited company, was established on 19 December 2007 in Agra, Uttar Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232UP2007PTC034304. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rahul Agarwal (Director), Chetan Gautam (Director), Abhinav Agarwal (Director). Its latest AGM occurred on 29 September 2012, with the balance sheet filed on 31 March 2012. It is based at 19/7B, Jagannath Puram, Agra, Uttar Pradesh, 282001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232UP2007PTC034304

  • Registration Number

    034304

  • Incorporation Date

    19 December 2007

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 18 Year, 1 Month
  • Last Filing with ROC 31 Mar 2012
Company report

Byron Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Byron Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Byron Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rahul Agarwal Director 19 Dec 2007 Current
Chetan Gautam Director 19 Dec 2007 Current
Abhinav Agarwal Director 19 Dec 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Byron Pharma.

Enhance accessibility to Byron Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Byron Pharma revenue growth over time
Byron Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Byron Pharma?

Unlock access to Byron Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Byron Pharma?

Unlock and access historical data on people associated with Byron Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Byron Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Byron Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Byron Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Byron Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2012 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Byron Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Kanpur. was documented.

  • Director Appointment

    Progress on Rahul Agarwal was appointed as a Director was appointed as a Director on 19 Dec 2007 & has been associated with this company since 18 years 1 month . was documented.

  • Director Appointment

    The activity Chetan Gautam was appointed as a Director was appointed as a Director on 19 Dec 2007 & has been associated with this company since 18 years 1 month . was completed.

  • Director Appointment

    The activity Abhinav Agarwal was appointed as a Director was appointed as a Director on 19 Dec 2007 & has been associated with this company since 18 years 1 month . was completed.

  • Company Incorporation

    Byron Pharma Private Limited was registered on 19 Dec 2007 with Roc Kanpur & aged 18 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Byron Pharma Private Limited?

The CIN of Byron Pharma Private Limited is U24232UP2007PTC034304.

Where is Byron Pharma Private Limited headquartered?

Byron Pharma Private Limited is headquartered at 19/7B, Jagannath Puram, Agra, Uttar Pradesh, 282001.

When was Byron Pharma Private Limited incorporated?

Byron Pharma Private Limited was incorporated on 19 December 2007.

Who are the current directors of Byron Pharma Private Limited?

The current directors of Byron Pharma Private Limited are

What is the primary industry of Byron Pharma Private Limited?

The primary industry of Byron Pharma Private Limited is Chemicals.

Is Byron Pharma Private Limited a listed company?

Byron Pharma Private Limited is unlisted.

What is the capital structure of Byron Pharma Private Limited?

The authorized capital of Byron Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available